Results
1438
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,438 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PLT | AU$0.74 | -2.0% | 91.0% | AU$130.6m | AU$1.30 | PS1.8x | E106.4% | n/a | Diversified Financials | ||
4480 | JP¥4,170.00 | 11.9% | -19.0% | JP¥135.3b | JP¥5,800.00 | PE50.6x | E28.7% | n/a | Healthcare | ||
A179900 | ₩32,500.00 | 14.0% | 48.1% | ₩514.2b | ₩60,000.00 | PS25.6x | E122.7% | 0% | Tech | ||
CTT | AU$1.39 | 9.9% | -60.0% | AU$566.1m | AU$3.12 | PE27.3x | E26.7% | n/a | Retail | ||
688408 | CN¥62.18 | 4.1% | 21.2% | CN¥12.5b | CN¥59.89 | PE27.1x | E25.8% | 0.9% | Capital Goods | ||
517522 | ₹606.75 | -2.2% | -28.2% | ₹30.8b | ₹772.00 | PE42.9x | E33.5% | 0.3% | Materials | ||
A067310 | ₩19,910.00 | -0.4% | -2.4% | ₩944.2b | ₩31,666.67 | PB3.2x | E96.3% | 0.3% | Semiconductors | ||
A204620 | ₩4,200.00 | 12.6% | 19.3% | ₩238.5b | ₩7,100.00 | PS2.2x | E72.4% | n/a | Commercial Services | ||
CUV | AU$15.62 | 0.7% | -12.0% | AU$782.2m | AU$30.32 | PE25.9x | E26.7% | 0.3% | Pharmaceuticals & Biotech | ||
300181 | CN¥14.80 | -0.7% | 25.0% | CN¥10.4b | n/a | PE24.3x | E22.3% | 3.0% | Pharmaceuticals & Biotech | ||
505283 | ₹1,366.10 | 4.0% | 99.6% | ₹88.5b | ₹1,705.00 | PE66.4x | E29.8% | 0.5% | Capital Goods | ||
A441270 | ₩9,350.00 | 0.5% | 16.1% | ₩345.7b | ₩11,500.00 | PE22.2x | E36.4% | n/a | Tech | ||
ACI | ₹703.20 | -2.8% | 32.1% | ₹86.8b | ₹757.20 | PE27.2x | E28.9% | 0.4% | Materials | ||
A178320 | ₩32,700.00 | 0.5% | 78.0% | ₩1.8t | ₩39,333.33 | PE169.3x | E58.7% | 0% | Tech | ||
YGG | ฿1.27 | -37.7% | -83.3% | ฿764.5m | ฿10.75 | PE11.1x | E33.5% | 21.1% | Media | ||
CALTX | SEK 205.80 | 0.1% | 146.9% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
GIG | NOK 30.00 | 1.4% | 15.2% | NOK 4.0b | NOK 45.03 | PE18.7x | E37.4% | n/a | Consumer Services | ||
VOW | NOK 6.90 | 1.5% | -52.1% | NOK 785.5m | NOK 11.00 | PB2x | E97.6% | 0% | Commercial Services | ||
ADOC | €5.25 | -26.9% | 35.1% | €79.0m | €6.30 | PS13.1x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$33.09 | 4.1% | 97.1% | US$5.1b | US$29.83 | PS28.3x | E60.9% | n/a | Semiconductors | ||
KEBNI B | SEK 1.51 | -2.5% | 9.6% | SEK 409.4m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
EH | US$15.42 | 7.2% | -20.0% | US$998.6m | US$24.98 | PS45.1x | E74.3% | n/a | Capital Goods | ||
2937 | CN¥22.60 | 7.0% | -13.9% | CN¥6.7b | CN¥34.33 | PE23.4x | E27.7% | 2.7% | Tech | ||
6643 | NT$1,400.00 | 8.9% | 72.3% | NT$58.5b | NT$1,409.99 | PE143.7x | E35.3% | 0.5% | Semiconductors |